Lyell Immunopharma to Participate in Morgan Stanley Global Healthcare Conference
Lyell Immunopharma (Nasdaq: LYEL) announced that its senior management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 1:05 p.m. ET. The event will focus on the company’s innovative approaches to T-cell reprogramming aimed at treating solid tumors.
A live webcast can be accessed via the investor relations section of Lyell's website, with a replay available for 90 days post-presentation.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced today that members of its senior management team will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, at 1:05 p.m. ET.
A live webcast of the fireside chat can be accessed through the investor relations section of the Company’s website at www.lyell.com. A replay of the webcast will be available on the Company’s website for 90 days following the presentation.
About Lyell Immunopharma, Inc.
Lyell is a clinical-stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors. The Company is advancing a pipeline of therapies designed to address what it believes are the primary barriers that limit consistent, reliable and curative responses to adoptive T-cell therapy: T-cell exhaustion and lack of durable stemness, which includes the ability to proliferate, persist and self-renew, as well as generate differentiated effector cell progenies to provide durable anti-tumor functionality. Lyell is applying its proprietary ex vivo genetic and epigenetic reprogramming technology platforms, Gen-R™ and Epi-R™, to address these barriers in order to develop new medicines with improved, durable and potentially curative clinical outcomes. Lyell is based in South San Francisco, California and Seattle and Bothell, Washington. To learn more, please visit www.lyell.com.
Contact:
Ellen Rose
Senior Vice President, Communications and Investor Relations
erose@lyell.com
FAQ
What time is the Lyell Immunopharma fireside chat on September 12, 2022?
Where can I watch the Lyell Immunopharma fireside chat?
What is the purpose of the fireside chat at the Morgan Stanley conference?
How long will the replay of the Lyell Immunopharma webcast be available?
What is the key focus of Lyell Immunopharma's research?
